Serum leptin, adiponectin and tumor necrosis factor-α in hyperlipidemic rats with/without concomitant diabetes mellitus

Molecular Medicine

Volumn 17, Issue 1-2, 2011, Pages 36-40

  Margoni, Angeliki ^a   Perrea, Despoina N ^a   Vlachos, Ioannis ^a   Prokopaki, Georgia ^a   Pantopoulou, Alkistis ^a   Fotis, Lambros ^a   Kostaki, Maria ^a   Papavassiliou, Athanasios G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STREPTOZOCIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIPID DIET; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

ADIPONECTIN; ANIMALS; BIOLOGICAL MARKERS; DIABETES COMPLICATIONS; DIABETES MELLITUS; HYPERLIPIDEMIAS; LEPTIN; MALE; OBESITY; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78651502671     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00167     Document Type: Article

References (41)

1. Havel PJ. (2002) Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr. Opin. Lipidol. 13:51-59.
2. Meier U, Gressner AM. (2004) Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin. Chem. 50:1511-1525.
3. Havel PJ. (2004) Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes. 53(Suppl 1):S143-S151.
4. Ahima RS. (2006) Adipose tissue as an endocrine organ. Obesity. 14(Suppl 5):242S-249S.
5. Ahima RS. (2006) Metabolic actions of adipocyte hormones: focus on adiponectin. Obesity. 14(Suppl 1): 9S-15S.
6. Kadowaki T, et al. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116:1784-1792.
7. Gannagé-Yared MH, et al. (2006) Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur. J. Endocrinol. 155:167-176.
8. Yan E, et al. (2008) Insulin, hs-CRP, leptin, and adiponectin. An analysis of their relationship to the metabolic syndrome in an obese population with an elevated waist circumference. Metab. Syndr. Relat. Disord. 6:64-73.
9. Silha JV, et al. (2003) Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur. J. Endocrinol. 149:331-335.
10. Oda N, et al. (2008) The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism. 57:268-273.
11. Considine RV, et al. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334:292-295.
12. Maffei M, et al. (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1:1155-1161.
13. Drevon CA. (2005) Fatty acids and expression of adipokines. Biochim. Biophys. Acta. 1740:287-292.
14. Ravussin E, Smith SR. (2002) Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus. Ann. N. Y.Acad. Sci. 967:363-378.
15. Anderlová K, et al. (2006) The influence of verylow-calorie-diet on serum leptin, soluble leptin receptor, adiponectin and resistin levels in obese women. Physiol. Res. 55:277-283.
16. Kiess W, et al. (1998) Serum leptin levels in children and adolescents with insulin-dependent diabetes mellitus in relation to metabolic control and body mass index. Eur. J. Endocrinol. 138:501-509.
17. Reinehr T, Kratzsch J, Kiess W, Andler W. (2005) Circulating soluble leptin receptor, leptin, and insulin resistance before and after weight loss in obese children. Int. J. Obes. (Lond) 29:1230-1235.
18. Leth H, et al. (2008) Elevated levels of highmolecular-weight adiponectin in type 1 diabetes. J. Clin. Endocrinol. Metab. 93:3186-3191.
19. Galler A, et al. (2007) Elevated serum levels of adiponectin in children, adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal study. Eur. J. Endocrinol. 157:481-489.
20. Hotta K, et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20:1595-1599.
21. Weyer C, et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86:1930-1935.
22. Yamauchi T, et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7:941-946.
23. Argiles JM, Lopez-Soriano J, Busquets S, Lopez-Soriano FJ. (1997) Journey from cachexia to obesity by TNF. FASEB J. 11:743-751.
24. Warne JP. (2003) Tumour necrosis factor alpha: a key regulator of adipose tissue mass. J. Endocrinol. 177:351-355.
25. Feugeas JP, et al. (1997) Influence of metabolic and genetic factors on tumour necrosis factoralpha and lymphotoxin-alpha production in insulin-dependent diabetes mellitus. Diabetes Metab. 23:295-301.
26. Lechleitner M, Koch T, Herold M, Hoppichler F. (1999) Relationship of tumor necrosis factoralpha plasma levels to metabolic control in type 1 diabetes. Diabetes Care. 22:1749.
27. Spiegelman BM, Hotamisligil GS. (1993) Through thick and thin: wasting, obesity, and TNF alpha. Cell. 73:625-627.
28. Neeley WE. (1972) Simple automated determination of serum or plasma glucose by a hexokinaseglucose-6-phosphate dehydrogenase method. Clin. Chem. 18:509-515.
29. Havel PJ, et al. (2000) Effects of streptozotocininduced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes. 49:244-252.
30. Wang MY, et al. (2010) Leptin therapy in insulindeficient type I diabetes. Proc. Natl. Acad. Sci. U. S. A. 107:4813-4819.
31. Tudurí E, et al. (2009) Inhibitory effects of leptin on pancreatic alpha-cell function. Diabetes. 58:1616-1624.
32. Imagawa A, et al. (2002) Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care. 25:1665-1666.
33. Satoh H, Fujii S, Tsutsui H. (2010) The highmolecular weight (HMW) form of adiponectin is a significant surrogate marker for the prediction of type 2 diabetes mellitus in the Japanese population. Nutr. Metab. Cardiovasc. Dis. 20:e9-e10.
34. Nakashima R, et al. (2006) Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J. Clin. Endocrinol. Metab. 91:3873-3877.
35. Seino Y, Hirose H, Saito I, Itoh H. (2007) High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabolism. 56:1493-1499.
36. Jansson PA, et al. (2003) A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin. FASEB J. 17:1434-1440.
37. Nilsson PM, et al. (2006) Plasma adiponectin levels in relation to carotid intima media thickness and markers of insulin resistance. Arterioscler. Thromb. Vasc. Biol. 26:2758-2762.
38. Shargorodsky M, et al. (2009) Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis? Int. J. Obes. (Lond). 33:553-558.
39. Rydén M, Arner P. (2007) Tumour necrosis factoralpha in human adipose tissue-from signaling mechanisms to clinical implications. J. Intern. Med. 262:431-438.
40. Lechleitner M, Koch T, Herold M, Dzien A, Hoppichler F. (2000) Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. J. Intern. Med. 248:67-76.
41. Foss MC, Foss NT, Paccola GM, Silva CL. (1992) Serum levels of tumor necrosis factor in insulindependent diabetic patients. Braz. J. Med. Biol. Res. 25:239-242.